This article is more than 5 years old. Information may no longer be current.

VIDEO: IRIS Registry study shows diabetic macular edema undertreated in US

ByJeffrey R. Willis, MD, PhD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Jeffrey R. Willis, MD, PhD, assistant medical director at Genentech, discusses a large retrospective study using the IRIS Registry to observe patients identified with diabetic macular edema and the treatments most used. The study found most patients were not treated regularly enough over a 1-year interval.